MERIDIAN BIOSCIENCE INC: key financial figures for fiscal year 2022 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2022)
- $333.0M
- Net Income/Loss (FY2022)
- $42.5M
- Total Assets (FY2022)
- $463.1M
- Total Equity (FY2022)
- $368.1M
- Cash Flows from Operating Activities (FY2022)
- $82.4M
Source: MERIDIAN BIOSCIENCE INC 10-K filing (FY2022). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
